Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Osteoporosis
How do you use P1NP in your clinical practice to guide management of osteoporosis?
Related Questions
Would you consider using Evenity in an elderly patient with rate controlled atrial fibrillation without history of MI or CVA?
Would you have concerns about combining romosuzumab and IVIG in a patient with dermatomyositis and osteoporosis?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
What is your approach to management of methotrexate osteopathy?
Is there any concern with starting romosozumab in a patient who is taking raloxifene for a history of breast cancer?
What is your experience with using anabolic therapy for treatment of osteoporosis in patients with EtOH cirrhosis and is one agent preferred over another (PTH analogue vs Evenity)?
Is there any contraindication for use of Invisalign teeth aligners in patients undergoing treatment for osteoporosis?
How should we interpret DXA scans in patients with Ankylosing Spondylitis who have ankylosis of the spine?
Is elevated bone specific alkaline phosphatase an absolute contraindication to teriparatide?
Would you stop romosozumab if a patient developed mild asymptomatic hypocalcemia while on treatment?
